KUKAVICA, DENI
 Distribuzione geografica
Continente #
NA - Nord America 224
EU - Europa 180
AS - Asia 64
OC - Oceania 3
Totale 471
Nazione #
US - Stati Uniti d'America 220
IE - Irlanda 102
IT - Italia 43
CN - Cina 41
SG - Singapore 19
FI - Finlandia 13
DE - Germania 12
CA - Canada 4
AT - Austria 3
GB - Regno Unito 3
AU - Australia 2
JP - Giappone 2
BE - Belgio 1
CZ - Repubblica Ceca 1
FR - Francia 1
IN - India 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
Totale 471
Città #
Dublin 102
Chandler 60
Shanghai 26
Boardman 22
Ashburn 20
Beijing 13
Helsinki 13
Singapore 12
Lawrence 9
Medford 9
Princeton 9
Milan 8
San Genesio Ed Uniti 7
Cagliari 4
New York 4
Pavia 4
Worcester 4
Los Angeles 3
Manchester 3
Pozzuolo Martesana 3
Toronto 3
Vienna 3
Wilmington 3
Chicago 2
Melbourne 2
Parma 2
Piscataway 2
Rome 2
Rozzano 2
San Francisco 2
Tokyo 2
Auckland 1
Berlin 1
Brno 1
Brussels 1
Fairfield 1
Forest City 1
Hangzhou 1
Jacksonville 1
Kingston 1
Paris 1
Pune 1
Riga 1
San Jose 1
Seattle 1
Taipei 1
Turin 1
Varenna 1
Woodbridge 1
Totale 378
Nome #
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 47
Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy 47
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 46
HERG Channel Agonists: A Novel, Substrate-Based Therapeutic Approach for Long QT Syndrome 44
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 42
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 32
Arrhythmic Mitral Valve Prolapse: Introducing an Era of Multimodality Imaging-Based Diagnosis and Risk Stratification. 31
Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy? 30
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply 28
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 28
Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5 26
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 26
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 20
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 18
Unexpected impairment of INa current underpins reentrant arrhythmias in a knock-in swine model of Timothy syndrome 11
Prevention of Sudden Death and Management of Ventricular Arrhythmias in Arrhythmogenic Cardiomyopathy 9
Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in Phospholamban Gene 4
Totale 489
Categoria #
all - tutte 3.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 1 0 1 4 0
2020/202115 0 0 0 0 0 5 0 4 2 1 3 0
2021/202257 0 0 2 0 0 0 0 1 0 27 3 24
2022/2023219 22 17 10 7 18 16 2 7 115 0 3 2
2023/2024130 18 11 4 12 5 21 25 5 1 6 8 14
2024/202562 27 19 10 3 3 0 0 0 0 0 0 0
Totale 489